Bag3 Mutation Associated Dilated Cardiomyopathy clinical trials

Explore recruiting bag3 mutation associated dilated cardiomyopathy clinical trials.

Recruiting bag3 mutation associated dilated cardiomyopathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bag3 Mutation Associated Dilated Cardiomyopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2, Open-Label, Dose Finding Study to Investigate the Safety, Tolerability, and Efficacy of ALXN2350 Gene Therapy in Adult Participants with Symptomatic BAG3 Mutation-Associated Dilated Cardiomyopathy

Spain, Italy, Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Bag3 Mutation Associated Dilated Cardiomyopathy trials by city

Bag3 Mutation Associated Dilated Cardiomyopathy in Toronto Bag3 Mutation Associated Dilated Cardiomyopathy in Vancouver Bag3 Mutation Associated Dilated Cardiomyopathy in Montreal Bag3 Mutation Associated Dilated Cardiomyopathy in Calgary Bag3 Mutation Associated Dilated Cardiomyopathy in Edmonton Bag3 Mutation Associated Dilated Cardiomyopathy in Ottawa Bag3 Mutation Associated Dilated Cardiomyopathy in Winnipeg Bag3 Mutation Associated Dilated Cardiomyopathy in Quebec City Bag3 Mutation Associated Dilated Cardiomyopathy in Hamilton Bag3 Mutation Associated Dilated Cardiomyopathy in Kitchener Bag3 Mutation Associated Dilated Cardiomyopathy in London Bag3 Mutation Associated Dilated Cardiomyopathy in Halifax Bag3 Mutation Associated Dilated Cardiomyopathy in New York Bag3 Mutation Associated Dilated Cardiomyopathy in Los Angeles Bag3 Mutation Associated Dilated Cardiomyopathy in Chicago Bag3 Mutation Associated Dilated Cardiomyopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease